Explores adaptive design methodologies, their advantages in accelerating innovation, and the statistical and regulatory complexities they introduce.

Provides an overview of vaccine biology, development pathways, and current research trends shaping the future of immunization.

Presents practical guidance from an experienced reviewer on strengthening post-market surveillance and developing effective risk management strategies

Explores opportunities and challenges for implementing decentralized clinical trials in Africa to improve inclusivity and operational efficiency.

Highlights the role of ACRNs in expanding research infrastructure and improving access to quality clinical studies and medicines across Africa.

Examines how pharmacoepidemiology can enhance medicine safety surveillance and bridge existing post-market monitoring gaps in Africa

AVAREF’s initiatives to strengthen clinical trial oversight, build regulatory capacity, and promote harmonization across African countries.

AVAREF’s initiatives to strengthen clinical trial oversight, build regulatory capacity, and promote harmonization across African countries.

Shares findings from the Larissa I Phase I study on the Rift Valley fever vaccine candidate, focusing on safety, immunogenicity, and lessons for future trials.

Discusses current approaches to post-market drug surveillance, emphasizing regulatory best practices and international collaboration for medicine safe

Introduces the concept of informativeness in clinical research and demonstrates how the Informativeness Assessment Tool supports scientific design and better study outcomes. & Presents ongoing global and regional initiatives to digitize clinical trial submissions, featuring insights from the DAC team and nuvoteQ on electronic CTA systems.

Explores how the Pan African Clinical Trials Registry (PACTR) promotes transparency, accountability, and public access to clinical trial information across the continent

An in-depth look at Zimbabwe’s pharmacovigilance system for monitoring vaccine safety, highlighting lessons learned from AEFI reporting and analysis.